Modifications in the MDR Era: The Ambiguities of “Significant Change”

article image

The EU Medical Device Regulation includes a crucial grace period to help current devices transition to the new standards in a challenging environment. But big questions linger over what device modifications will qualify as a “significant change” nullifying transitional certificates and requiring an MDR-level assessment.

How to handle device modifications is one of the thorniest, yet enduring, regulatory questions in the global medtech arena. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: